The isoflavone genistein inhibits copper and peroxyl radical mediated low density lipoprotein oxidation in vitro

Atherosclerosis

Volumn 140, Issue 2, 1998, Pages 341-347

  Kerry, Nicole ^a   Abbey, Mavis ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b CSIRO   (Australia)

Author keywords

Genistein; Low density lipoprotein; Oxidation

Indexed keywords

COPPER; FREE RADICAL; GENISTEIN; ISOFLAVONE DERIVATIVE; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; PEROXY RADICAL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; ELECTROPHORETIC MOBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIPID OXIDATION; PRIORITY JOURNAL; SOYBEAN;

AMIDINES; ARTERIOSCLEROSIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COPPER SULFATE; DENSITOMETRY; ENZYME INHIBITORS; GENISTEIN; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MALONDIALDEHYDE; OXIDANTS;

EID: 0031728288     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00138-5     Document Type: Article

References (48)

1. Setchell KDR, Borriello SP, Kirk DN, Axelson M. Nonsteroidal estrogens of dietary origin: Possible role in hormone-dependent disease. Am J Clin Nutr. 40:1984;569-578.
2. Akiyama T, Ogawara H. Use and specificity of genistein as inhibitor of protein tyrosine kinase. Methods Enzymol. 201:1991;362-370.
3. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 262:1987;5592-5595.
4. Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, Schweigerer L. Genistein, a dietary inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA. 90:1993;2690-2694.
5. Messina MJ, Persky V, Setchell KDR, Barnes S. Soy intake and cancer risk:A review of the in vitro and in vivo data. Nutr Cancer. 21:1994;113-131.
6. Jha H.C., von Recklinghausen G., Zilliken F. Inhibition of in vitro microsomal lipid peroxidation by isoflavonoids. Biochem Pharmacol. 34:1985;1367-1369.
7. Pratt DE, Birac PM. Source of antioxidant activity of soybeans and soy products. J Food Sci. 44:1979;1720-1722.
8. Record IR, Dreosti IE, McInerney J. The antioxidant activity of genistein in vitro. J Nutr Biochem. 6:1995;481-485.
9. Wei H, Wei L, Frenkel K, Bowen R, Barnes S. Inhibition of tumour promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr Cancer. 20:1993;1-12.
10. Dreosti IE. In: Dreosti IE, editor. Trace Elements, Micronutrients and Free Radicals. Free Radical Pathology and the Genome. New Jersey: Humana Press, 1991;149-170.
11. Hertog MG, Feskens EJM, Hollman PCH, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet 1993:342;1001-1011.
12. Esterbauer H, Striegl G, Puhl H, Oberreither S, Rotheneder M, El-Saadani M, Jurgens G. The role of vitamin E and carotenoids in preventing oxidation of low density lipoproteins. Ann NY Acad Sci. 570:1989;254-267.
13. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781-786.
14. Stampfer MJ, Hennekkens CH, Manson JE, Colditz GA, Rosner B, Willet WC. Vitamin E consumption and risk of coronary heart disease in women. New Engl J Med. 328:1993;1444-1449.
15. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willet WC. Vitamin E consumption and risk of coronary heart disease in men. New Engl J Med. 328:1993;1450-1456.
16. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: Modifications of LDL that increase its atherogenicity. New Engl J Med. 320:1989;915-924.
17. Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low-density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA. 84:1987;2995-2998.
18. Ku G, Thomas CE, Akeson AL, Jackson RL. Induction of interleukin 1 beta expression from human peripheral blood monocyte-derived macrophages by 9-hydroxyoctadecadienoic acid. J Biol Chem. 267:1992;14183-14188.
19. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA. 76:1979;333-337.
20. Parthasarathy S, Printz DJ, Boyd D, Joy L, Steinberg D Macrophage oxidation of low density lipoprotein generates a modified form recognised by the scavenger receptor. Arterioscler Thromb. 6:1986;505-510.
21. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA. 81:1984;3883-3887.
22. Parthasarathy S, Young SG, Witztum JL, Pittman RC, Steinberg D. Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest. 77:1986;641-644.
23. Suzukawa M, Abbey M, Clifton P, Nestel P. Effects of supplementing with vitamin E on the uptake of low density lipoprotein and the stimulation of cholesteryl ester formation in macrophages. Atherosclerosis. 110:1994;77-86.
24. Bjorkhem I, Henriksson-Freyschuss A, Breuer O, Diczfalusy U, Berglund L, Henriksson P. The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arterioscler Thromb. 11:1991;15-22.
25. Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Ooshima A, Yoshida H, Kawai C. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA. 84:1987;5928-5931.
26. Williams RJ, Motterim JM, Sharp CH, Gallagher PJ. Dietary vitamin E and the attenuation in early lesion development in modified Watanabe rabbits. Atherosclerosis. 94:1992;153-159.
27. Hodgson JM, Croft KD, Puddey IB, Mori TA, Beilin LJ. Soybean isoflavonoids and their metabolic products inhibit in vitro lipoprotein oxidation in serum. J Nutr Biochem. 7:1996;664-669.
28. Rifici VA, Schneider SH, Khachadurian AK. Stimulation of low-density lipoprotein oxidation by insulin and insulin like growth factor I. Atherosclerosis. 107:1994;99-108.
29. Tsai E.C., Chait A. Inhibition of low density lipoprotein oxidation by genistein. J Invest Med 1995;43:245A (abstract).
30. Walter ED. Genistin (an isoflavonoid glucoside) and its aglycone, genistein, from soybeans. J Am Chem Soc. 63:1941;3273-3276.
31. Suzukawa M, Abbey M, Howe PRC, Nestel PJ. Effects of fish oil fatty acids on low density lipoprotein size, oxidisability, and uptake by macrophages J Lipid Res 1995;36:473-484.
32. Chung BH, Segrest JP, Ray MJ.et al. Single vertical spin gradient ultracentrifugation. Methods Enzymol. 128:1986;181-209.
33. Lowry OH, Rosenberg NJ, Farr AL, Randall RJ. Protein measurements with the folin phenol reagent. J Biol Chem. 193:1951;265-275.
34. Clifton PM, Chang L, Mackinnon AM. Development of an automated Lowry protein assay for the Cobas-Bio centrifugal analyser. Anal Biochem. 172:1988;165-168.
35. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun. 6:1989;67-75.
36. King RA, Broadbent JL, Head RJ. Absorption and excretion of the soy isoflavone genistein in rats. J Nutr. 126:1996;176-182.
37. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 52:1978;302-310.
38. Abbey M, Nestel PJ, Baghurst PA. Antioxidant vitamins and low-density-lipoprotein oxidation. Am J Clin Nutr. 58:1993;525-532.
39. Morel DW, Hessler JR, Chisolm GM. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res. 24:1983;1070-1076.
40. Ruiz-Larrea MB, Hohan AR, Paganga G, Miller N, Bolwell GP, Rice-Evans CA. Antioxidant activity of phytoestrogenic isoflavones. Free Radic Res. 26:1997;63-70.
41. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med. 20:1996;933-956.
42. van Acker SABE, van den Berg D, Tromp MNJL, Griffionen DH, van Bennekom WP, van der Vijgh WJF, Bast A. Structural aspects of antioxidant activity of flavonoids. Free Radic Biol Med 1996;20:331-342.
43. Esterbauer H, Puhl H, Dieber-Rotheneder M, Waeg G, Rabl H. Effect of antioxidants on oxidative modification of LDL. Ann Med. 23:1991;573-581.
44. Lehtonen JYA, Adlercreutz H, Kinnunen PKJ. Binding of daidzein to liposomes. Biochim Biophys Acta. 1285:1996;91-100.
45. Nestel PJ, Yamashita T, Sasahara T, Pomeroy S, Dart A, Komesaroff P, Owen A, Abbey M. Soy isoflavonoids improve systemic arterial compliance but not plasma lipids in menopausal women. Arterioscl Thromb Vasc Biol. 17:1997;3392-3398.
46. Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phtyo-oestrogens in Japanese men. Lancet. 342:1993;1209-1210.
47. Gooderham MJ, Adlercreutz H, Ojala ST, Wahala K, Holub BJ. A soy protein isolate rich in genistein and daidzein and its effect on plasma isoflavone concentrations, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men. Human Clin Nutr. 126:1996;2000-2006.
48. Cook NC, Samman S. Flavonoids - Chemistry, metabolism, cardioprotective effects, and dietary sources. J Nutr Biochem. 7:1996;66-76.